ClinicalTrials.gov
ClinicalTrials.gov Menu

Morphological Analysis of the Pineal Gland in Pediatric Retinoblastoma Patients Using Magnetic Resonance Imaging

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01884194
Recruitment Status : Completed
First Posted : June 21, 2013
Last Update Posted : December 29, 2015
Sponsor:
Information provided by (Responsible Party):
Thi Thai Hien Pham, Charite University, Berlin, Germany

May 24, 2013
June 21, 2013
December 29, 2015
November 2013
December 2014   (Final data collection date for primary outcome measure)
Malignancy criteria of pineal gland [ Time Frame: clinical follow-up 1-year after baseline imaging ]
size of pineal gland solid or cystic component (all at baseline)
Same as current
Complete list of historical versions of study NCT01884194 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Morphological Analysis of the Pineal Gland in Pediatric Retinoblastoma Patients Using Magnetic Resonance Imaging
Morphological Analysis of the Pineal Gland in Pediatric Retinoblastoma Patients Using Magnetic Resonance Imaging
MRI is useful for diagnosing pinealoblastoma in retinoblastoma patients
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Retrospective
Not Provided
Not Provided
Non-Probability Sample
pediatric patients with retinoblastoma
  • Retinoblastoma
  • Pineoblastoma
Not Provided
  • Retinoblastoma patients
    patients with diagnosed retinoblastoma
  • non-retinoblastoma patients
    aged matched control cohort without the diagnosis of ocular or brain tumor
Pham TT, Siebert E, Asbach P, Willerding G, Erb-Eigner K. Magnetic resonance imaging based morphologic evaluation of the pineal gland for suspected pineoblastoma in retinoblastoma patients and age-matched controls. J Neurol Sci. 2015 Dec 15;359(1-2):185-92. doi: 10.1016/j.jns.2015.10.046. Epub 2015 Oct 28.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
80
100
February 2015
December 2014   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • diagnosis of retinoblastoma
  • brain MRI available

Exclusion Criteria:

  • insufficient quality of brain MRI
Sexes Eligible for Study: All
up to 50 Years   (Child, Adult)
No
Contact information is only displayed when the study is recruiting subjects
Germany
 
 
NCT01884194
RTB_0305_outcome
No
Not Provided
Not Provided
Thi Thai Hien Pham, Charite University, Berlin, Germany
Charite University, Berlin, Germany
Not Provided
Not Provided
Charite University, Berlin, Germany
December 2015